Alzheimer’s drug now has full FDA approval, which means Medicare will pay for it
U.S. officials have granted full approval to a closely watched Alzheimer’s drug for patients with early stages of the disease.
U.S. officials have granted full approval to a closely watched Alzheimer’s drug for patients with early stages of the disease.
The U.S. Food and Drug Administration has approved the first drug developed specifically to reduce excessive sweating, a common condition that can cause anxiety. Dermira Inc. said Friday its Qbrexza was approved for excessive underarm sweating. The drug is inside a cloth wiped over the skin daily to block sweat glands from activating. Dermira refused to disclose the price. Qbrexza…